Companies: 10,786     total market cap: โ‚น12541.560 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
BioCryst Pharmaceuticals
BCRX
#4384
Rank
โ‚น224.27 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
โ‚น894.22
Share price
0.68%
Change (1 day)
39.27%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

Revenue for BioCryst Pharmaceuticals (BCRX)

Revenue in 2025 (TTM): โ‚น77.09 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚น81.61 Billion. an increase over the revenue in the year 2024 that were of โ‚น38.66 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for BioCryst Pharmaceuticals from 1996 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น78.53 B103.11%
2024 โ‚น38.66 B40.14%
2023 โ‚น27.58 B23.11%
2022 โ‚น22.41 B91.57%
2021 โ‚น11.69 B798.03%
2020 โ‚น1.30 B-62.59%
2019 โ‚น3.48 B141.15%
2018 โ‚น1.44 B-10.2%
2017 โ‚น1.60 B-10.2%
2016 โ‚น1.79 B-44.16%
2015 โ‚น3.20 B271.84%
2014 โ‚น0.86 B-19.45%
2013 โ‚น1.07 B-25.63%
2012 โ‚น1.43 B38.54%
2011 โ‚น1.03 B-62.83%
2010 โ‚น2.79 B-19.23%
2009 โ‚น3.46 B27.31%
2008 โ‚น2.71 B-2.76%
2007 โ‚น2.79 B916.33%
2006 โ‚น0.27 B3925.19%
2005 โ‚น6.83 M1672.84%
2004 โ‚น0.38 M-99.48%
2003 โ‚น74.39 M-12.57%
2002 โ‚น85.09 M-84.19%
2001 โ‚น0.53 B912.23%
2000 โ‚น53.18 M-54.57%
1999 โ‚น0.11 B-58.28%
1998 โ‚น0.28 B495.06%
1997 โ‚น47.15 M-49.55%
1996 โ‚น93.47 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Gilead Sciences
GILD
โ‚น2.746 T 3,265.31%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น4.083 T 4,903.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
โ‚น225.18 B 175.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น68.87 B-15.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น95.56 B 17.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น0.14 B-99.82%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น70.03 B-14.19%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com